Palisade Bio (PALI) Change in Accured Expenses (2010 - 2026)
Palisade Bio (PALI) posted quarterly Change in Accured Expenses of $2.6 million for Q1 2026, up 524.17% year-over-year from $410463.7 in Q1 2025, and up 594.31% quarter-over-quarter from $369000.0 in Q4 2025.
Powered by 
Analysis
Palisade Bio (PALI) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Change in Accured Expenses for 17 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 524.17% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $3.8 million (up 4089.47% YoY), while the FY2025 annual figure was $624000.0, up 1214.29% from the prior year.
- Change in Accured Expenses rose to $2.6 million in Q1 2026 per PALI's latest filing, from $369000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.6 million in Q1 2026 and bottomed at -$604000.0 in Q1 2025.
- Historically, Change in Accured Expenses has averaged $178647.1 across 5 years, with a median of $17000.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 637.5% — and 2025, when it soared 3825.0%.
- Palisade Bio's Change in Accured Expenses stood at $817000.0 in 2022, then tumbled by 165.48% to -$535000.0 in 2023, then fell by 8.79% to -$582000.0 in 2024, then surged by 163.4% to $369000.0 in 2025, then surged by 594.31% to $2.6 million in 2026.
- Business Quant data shows PALI's Change in Accured Expenses at $2.6 million in Q1 2026, $369000.0 in Q4 2025, and $785000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | -518,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -518,000.00 |
| Mar 31, 2026 | 2.56 Mn |
| Dec 31, 2025 | 369,000.00 |
| Sep 30, 2025 | -955,000.00 |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | -604,000.00 |
| Dec 31, 2024 | 292,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Dec 31, 2023 | -308,000.00 |
| Sep 30, 2023 | 183,000.00 |
| Jun 30, 2023 | 603,000.00 |
| Mar 31, 2023 | -970,000.00 |
| Dec 31, 2022 | -307,000.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | -439,000.00 |
| Dec 31, 2021 | -250,000.00 |
| Sep 30, 2021 | -12,000.00 |